Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: May 16, 2023
Reporting Period: This filing reports on events occurring on May 16, 2023, specifically regarding upcoming investor presentations.
Financial Metrics
This Form 8-K does not contain specific financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves as a disclosure of an investor presentation rather than a financial report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers have scheduled upcoming presentations to investors and analysts and intend to utilize the material provided in Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The company is providing an investor presentation (Exhibit 99.1) for use in upcoming meetings with investors and analysts.
Regulatory Note: The information in this Item 7.01 and the referenced Exhibit 99.1 is furnished pursuant to Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this filing.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated May 2023) for actual financial data and strategic outlook, as this 8-K only references it.
- Confirm the dates and details of the upcoming investor presentations mentioned by executive officers.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act and carries different liability standards than a standard 10-K or 10-Q.